相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between increased serum D-serine and cognitive gains induced by intensive cognitive training in schizophrenia
Rogerio Panizzutti et al.
SCHIZOPHRENIA RESEARCH (2019)
Cerebrospinal fluid D-serine concentrations in major depressive disorder negatively correlate with depression severity
Sayuri Ishiwata et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
D-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner
Kirsten C. Svane et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2018)
Potential and Challenges for the Clinical Use of D-Serine As a Cognitive enhancer
Gerson D. Guercio et al.
FRONTIERS IN PSYCHIATRY (2018)
Improvement in mismatch negativity generation during D-serine treatment in schizophrenia: Correlation with symptoms
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2018)
Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia
Darrick T. Balu et al.
ACS CHEMICAL NEUROSCIENCE (2018)
D-Amino Acid Oxidase-pLG72 Interaction and D-Serine Modulation
Loredano Pollegioni et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Acute Amino Acid D-Serine Administration, Similar to Ketamine, Produces Antidepressant-like Effects through Identical Mechanisms
I-Hua Wei et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Development of an UPLC-MS/MS method for simultaneous quantitation of 11 D-amino acids in different regions of rat brain: Application to a study on the associations of D-amino acid concentration changes and Alzheimer's disease
Zhe Li et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Astroglial versus Neuronal D-Serine: Fact Checking
Thomas Papouin et al.
TRENDS IN NEUROSCIENCES (2017)
Epigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice
Jiesi Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
ON or OFF?: Modulating the N-Methyl-D-Aspartate Receptor in Major Depression
Shi Yu Chan et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
An overview on D-amino acids
Giuseppe Genchi
AMINO ACIDS (2017)
Increased serum levels of serine enantiomers in patients with depression
Kenji Hashimoto et al.
ACTA NEUROPSYCHIATRICA (2016)
Serine enantiomers as diagnostic biomarkers for schizophrenia and bipolar disorder
Kenji Hashimoto
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
Increased serum levels of serine enantiomers in patients with depression
Kenji Hashimoto et al.
ACTA NEUROPSYCHIATRICA (2016)
Neurophysiological mechanisms of cortical plasticity impairments in schizophrenia and modulation by the NMDA receptor agonist D-serine
Joshua T. Kantrowitz et al.
BRAIN (2016)
Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction
Leila Birolo et al.
FEBS JOURNAL (2016)
Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model
Henry Sershen et al.
NEUROCHEMICAL RESEARCH (2016)
Low D-serine levels in schizophrenia: A systematic review and meta-analysis
Seo-Eun Cho et al.
NEUROSCIENCE LETTERS (2016)
The Rise and Fall of the D-Serine-Mediated Gliotransmission Hypothesis
Herman Wolosker et al.
TRENDS IN NEUROSCIENCES (2016)
D-Serine and Serine Racemas Are Associated with PSD-95 and Glutamatergic Synapse Stability
Hong Lin et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation
Yuko Fujita et al.
SCIENTIFIC REPORTS (2016)
D-Amino Acids in the Nervous and Endocrine Systems
Yoshimitsu Kiriyama et al.
SCIENTIFICA (2016)
Enantioselective inhibition of D-serine transport by (S)-ketamine
Nagendra S. Singh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond
Darrick T. Balu et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
D-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia
Francesco Errico et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Behavioral and cognitive effects of the N-methyl-D-aspartate receptor co-agonist D-serine in healthy humans: Initial findings
Raz Levin et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
Y. Iwata et al.
MOLECULAR PSYCHIATRY (2015)
Ketamine for depression: evidence, challenges and promise
Carlos A. Zarate et al.
WORLD PSYCHIATRY (2015)
D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
Ruin Moaddel et al.
PSYCHOPHARMACOLOGY (2015)
D-serine for the treatment of negative symptoms in individuals at clinical high risk of schizophrenia: a pilot, double-blind, placebo-controlled, randomised parallel group mechanistic proof-of-concept trial
Joshua T. Kantrowitz et al.
LANCET PSYCHIATRY (2015)
D-Serine in Neurobiology: CNS Neurotransmission and Neuromodulation
Sanaa K. Bardaweel et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2014)
The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72-two key proteins in D-serine catabolism in the brain
Pamela Cappelletti et al.
FEBS JOURNAL (2014)
Serine Racemase Regulated by Binding to Stargazin and PSD-95 POTENTIAL N-METHYL-D-ASPARTATE-α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID (NMDA-AMPA) GLUTAMATE NEUROTRANSMISSION CROSS-TALK
Ting Martin Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
C-H Lin et al.
MOLECULAR PSYCHIATRY (2014)
Chronic D-serine reverses arc expression and partially rescues dendritic abnormalities in a mouse model of NMDA receptor hypofunction
Darrick T. Balu et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
D-serine prevents cognitive deficits induced by acute stress
G. D. Guercio et al.
NEUROPHARMACOLOGY (2014)
Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: Impact of mouse models
Tatiana V. Lipina et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Changes in plasma D-serine, L-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment
Hidenaga Yamamori et al.
NEUROSCIENCE LETTERS (2014)
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2013)
Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy
Kee-Hong Choi et al.
BRITISH JOURNAL OF PSYCHIATRY (2013)
D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
Silvia Sacchi et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion
T. M. Ma et al.
MOLECULAR PSYCHIATRY (2013)
Neonatal Disruption of Serine Racemase Causes Schizophrenia-Like Behavioral Abnormalities in Adulthood: Clinical Rescue by D-Serine
Hiroko Hagiwara et al.
PLOS ONE (2013)
Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior
David-Marian Otte et al.
PLOS ONE (2013)
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction
Darrick T. Balu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A pilot double-blind comparison of D-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia
Marina Ermilov et al.
SCHIZOPHRENIA RESEARCH (2013)
D-serine as a gliotransmitter and its roles in brain development and disease
Marion R. Van Horn et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Add-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor
Hsien-Yuan Lane et al.
JAMA PSYCHIATRY (2013)
Brain D-amino acids: a novel class of neuromodulators
Jean-Pierre Mothet et al.
AMINO ACIDS (2012)
D-Amino acids in brain neurotransmission and synaptic plasticity
Jean-Marie Billard
AMINO ACIDS (2012)
Clinical and Cerebral Volumetric Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, in a Drug-Naive Patient with Major Depression
Chien-Han Lai et al.
BIOLOGICAL PSYCHIATRY (2012)
Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
Shunske Tanahashi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Thomas Papouin et al.
CELL (2012)
D-serine and schizophrenia: an update
Emerson A. Nunes et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency
Diana P. Prata et al.
HUMAN BRAIN MAPPING (2012)
Acute D-serine treatment produces antidepressant-like effects in rodents
Oz Malkesman et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex
Darrick T. Balu et al.
NEUROBIOLOGY OF DISEASE (2012)
Contributions of the D-serine pathway to schizophrenia
Viviane Labrie et al.
NEUROPHARMACOLOGY (2012)
Neuronal D-serine regulates dendritic architecture in the somatosensory cortex
Darrick T. Balu et al.
NEUROSCIENCE LETTERS (2012)
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Plasma levels of D-serine in Brazilian individuals with schizophrenia
Marilia A. Calcia et al.
SCHIZOPHRENIA RESEARCH (2012)
Association between the DAOA/G72 gene and bipolar disorder and meta-analyses in bipolar disorder and schizophrenia
Daniel J. Mueller et al.
BIPOLAR DISORDERS (2011)
Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
Surendra P. Singh et al.
CNS DRUGS (2011)
Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
Dana V. Ferraris et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
L. M. DeVito et al.
GENES BRAIN AND BEHAVIOR (2011)
Evidence for the interaction of D-amino acid oxidase with pLG72 in a glial cell line
Silvia Sacchi et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Effects of low-dose d-serine on recognition and working memory in mice
Patricia Bado et al.
PSYCHOPHARMACOLOGY (2011)
N-methyl-D-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
Joshua T. Kantrowitz et al.
BRAIN RESEARCH BULLETIN (2010)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice
V. Labrie et al.
GENES BRAIN AND BEHAVIOR (2010)
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
L. Verrall et al.
MOLECULAR PSYCHIATRY (2010)
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Giles E. Hardingham et al.
NATURE REVIEWS NEUROSCIENCE (2010)
The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia
Viviane Labrie et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Effect of ligand binding on human D-amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment
Laura Caldinelli et al.
PROTEIN SCIENCE (2010)
d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats
Toshiharu Shimazaki et al.
PSYCHOPHARMACOLOGY (2010)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2009)
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Viviane Labrie et al.
HUMAN MOLECULAR GENETICS (2009)
Increased d-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study
Gregor Habl et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase - Effect on schizophrenia susceptibility
Silvia Sacchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Synthesis and biological evaluation of D-amino acid oxidase inhibitors
Dana Ferraris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Changes in plasma glycine, L-serine, and D-serine levels in patients with schizophrenia as their clinical symptoms improve: Results from the Juntendo University Schizophrenia Projects (JUSP)
Tohru Ohnuma et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
Caroline Madeira et al.
SCHIZOPHRENIA RESEARCH (2008)
NMDA receptor regulation by D-serine: New findings and perspectives
Herman Wolosker
MOLECULAR NEUROBIOLOGY (2007)
Insights into the activation of brain serine racemase by the multi-PDZ domain glutamate receptor interacting protein, divalent cations and ATP
Florian Baumgart et al.
FEBS JOURNAL (2007)
D-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia
Louise Verrall et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Nitric oxide S-nitrosylates serine racemase, mediating feedback inhibition of D-serine formation
Asif K. Mustafa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
Correlation between plasma levels of glutamate, alanine and serine with severity of depression
Hideaki Mitani et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Modulation of D-serine levels via ubiquitin-dependent proteasomal degradation of serine racemase
Elena Dumin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis
Sevilla D. Detera-Wadleigh et al.
BIOLOGICAL PSYCHIATRY (2006)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
Serine racemase binds to PICK1: potential relevance to schizophrenia
K Fujii et al.
MOLECULAR PSYCHIATRY (2006)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices
M Shleper et al.
JOURNAL OF NEUROSCIENCE (2005)
D-amino acids in the central nervous system in health and disease
SA Fuchs et al.
MOLECULAR GENETICS AND METABOLISM (2005)
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
K Hashimoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine
JP Mothet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Serine racemase: Activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration
PM Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine
JD Andersen et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
I Chumakov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex
L Chen et al.
JOURNAL OF NEUROPHYSIOLOGY (2002)
分享论文
